Nureca Limited (NURECA.NS)
- Previous Close
288.95 - Open
287.50 - Bid --
- Ask --
- Day's Range
283.10 - 291.00 - 52 Week Range
253.50 - 468.80 - Volume
19,686 - Avg. Volume
31,120 - Market Cap (intraday)
2.86B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
343.92 - EPS (TTM)
0.83 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 24, 2022
- 1y Target Est
--
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales. It offers its products under the Dr Trust, Dr Physio, and Trumom brands. The company markets its products through e-commerce players, distributors, and retailers. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.
www.nureca.comRelated News
Performance Overview: NURECA.NS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NURECA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NURECA.NS
Valuation Measures
Market Cap
2.86B
Enterprise Value
1.54B
Trailing P/E
348.11
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.97
Price/Book (mrq)
1.45
Enterprise Value/Revenue
1.60
Enterprise Value/EBITDA
33.64
Financial Highlights
Profitability and Income Statement
Profit Margin
0.86%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
961.84M
Net Income Avi to Common (ttm)
8.22M
Diluted EPS (ttm)
0.83
Balance Sheet and Cash Flow
Total Cash (mrq)
1.22B
Total Debt/Equity (mrq)
1.40%
Levered Free Cash Flow (ttm)
--
Company Insights: NURECA.NS
NURECA.NS does not have Company Insights